Home|Journals Follow on Twitter| Subscribe to List

Directory for Medical Articles
 

Open Access

Original Research

Egypt. J. Exp. Biol. (Zoo.). 2009; 5(0): 331-339


FENUGREEK (TRIGONELLA FOENUM GRAECUM) AMELIORATES CYCLOPHOSPHAMIDE-INDUCED HISTOPATHOLOGICAL, HISTOCHEMICAL AND BIOCHEMICAL CHANGES IN THE LIVER OF ALBINO MICE

Saber A. Sakr, Hoda A. Mahran, Samah M. Abo-El-Yazid.

Abstract
Administration of cyclophosphamide to albino mice at a dose level of 7 mg / kg body weight, 3 times/ week for 8 weeks induced various histopathological changes in the liver such as hepatic tissue impairment, cytoplasmic vacuolization of the hepatocytes, congestion of blood vessels and leucocytic infiltrations. Moreover, the liver enzymes, ALT and AST, as well as glucose were increased in sera of treated mice. Histochemically, the hepatocytes showed increase in glycogen and decrease in total proteins, DNA and RNA. Treating animals with cyclophosphamide and aqueous extract of fenugreek seeds at a dose level of 0.4 mg/kg b. wt led to an improvement in both histopathological and histochemical pictures as well as biochemical parameters. These results proved that fenugreek had an ameliorative effect against liver injury induced by cyclophosphamide. This may be due to its antioxidant activity.

Key words: Cyclophosphamide, Mice, Fenugreek, Histology, Histochemistry, Biochemistry



Share this Article


Advertisement
Journal of Apitherapy

SUBMIT YOUR ARTICLE NOW


ScopeMed.com
BiblioMed Home
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright ScopeMed Information Services.